Biogen Medical Research
Multiple Sclerosis
Scientific Objectives
We are currently only accepting proposals from the United States.
The following areas of research are currently being considered:
- Diroximel Fumarate
- Transitioning from high efficacy therapies (e.g., B-cell depleting therapies) to diroximel fumarate or other fumarates.
- Natalizumab
- Examination of long-term outcomes
Research support is awarded on a highly competitive basis, and submission of research proposals in these areas of interest does not guarantee support will be awarded.